Lamivudine pulse therapy treats HBeAg-positive patients with normal ALT values.
Publication: Hepatitis Weekly
Publication Date: 27-DEC-04
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2004 DEC 27 - (NewsRx.com & NewsRx.net) -- Lamivudine pulse therapy treats HBeAg-positive patients with normal ALT values.
"Currently no therapy is given to patients with chronic hepatitis B virus (HBV) infection who are hepatitis B envelope antigen (HBeAg) positive with normal alanine aminotransferase (ALT) levels. Steroid priming has been shown to enhance T-helper-1 (Th-1) cell response. Lamivudine may restore immunologic competence against HBV by...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
